Blood & Cancer artwork

Breast cancer risk with HRT, statins and colorectal cancer, and SBRT for lung metastases

Blood & Cancer

English - November 03, 2020 09:00 - 9 minutes - 12.6 MB - ★★★★★ - 31 ratings
Medicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How to use antiemetics: Dr. Paul Hesketh reviews ASCO’s guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents
Next Episode: How I treat NSCLC in the era of checkpoint inhibitors and the COVID-19 pandemic

News from MDedge Hematology-Oncology:

New estimates for breast cancer risk with HRT: https://bit.ly/37VT0Pt
BMJ study: https://bit.ly/2TKDIVt
Lancet meta-analysis: https://bit.ly/3kUdbRl Single and multifraction SBRT found comparable for lung metastases: https://bit.ly/2HS36pR

Statins may lower risk of colorectal cancer: https://bit.ly/3kLbR37

Email Blood & Cancer at [email protected]. 

Follow us on Twitter @MDedgeHemOnc.

Twitter Mentions